Nonenzymatic glycation of type I collagen modifies interaction with UMR 201-10B preosteoblastic cells

Bone

Volumn 21, Issue 3, 1997, Pages 237-242

  Katayama, Y ^a   Celic, S ^a   Nagata, N ^b   Martin, T J ^a   Findlay, David M ^a,c  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Collagen; Diabetes mellitus; Glycation; Osteopenia; Preosteoblast

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; MESSENGER RNA; OSTEOCALCIN; OSTEOPONTIN; PLASTIC; RETINOIC ACID; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; BONE; BONE DENSITY; BONE MINERAL; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL LINE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; ENZYME ACTIVITY; GLYCATION; NONHUMAN; OSTEOBLAST; PROTEIN SECRETION; RAT; RECEPTOR BINDING;

ALKALINE PHOSPHATASE; ANIMALS; BLOTTING, NORTHERN; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; COLLAGEN; CROSS-LINKING REAGENTS; GENE EXPRESSION REGULATION; GLUCOSE-6-PHOSPHATE; GLYCOSYLATION END PRODUCTS, ADVANCED; OSTEOBLASTS; OSTEOPONTIN; RATS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; SIALOGLYCOPROTEINS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRETINOIN;

EID: 0030765082     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(97)00128-2     Document Type: Article

References (27)

1. Andrianarivo, A. G., Robinson, J. A., Mann, K. G., and Tracy, R. P. Growth on type I collagen promotes expression of the osteoblastic phenotype in human osteosarcoma MG-63 cells. J Cell Physiol 153:256-265; 1992.
2. Bouillon, R. Diabetic bone disease. Calcif Tissue Int 49:155-160; 1990.
3. Bouillon, R., Bex, M., Van Herck, E., Laureys, J., Dooms, L., Lesaffre, E., and Ravussin, E. Influence of age, sex, and insulin on osteoblast function: Osteoblast dysfunction in diabetes mellitus. J Clin Endocrinol Metab 80:1194-1202; 1995.
4. Brett, J., Schmidt, A. M., Yan, S. D., Zhou, Y. S., Weidman, E., Pinsky, D.. Nowygrod, R., Neeper, M., Przysiecki, C., and Shaw, A. Survey of the distribution of a newly characterized receptor for AGEs in tissue. Am J Pathol 143:1699-1712; 1993.
5. Brownlec, M. Glycation and diabetic complications. Diabetes 43:836-841; 1994.
6. Centrella, M., Horowitz, M. C., Wozey,J. M., and McCarthy, T. L. Transforming growth factor-β gene family members and bone. Endocr Rev 15:27-39; 1994.
7. Crowley, S. T., Brownlee, M., Edelstein, D., Satriano, J. A., Mori, T., Singhal, P. C., and Schlondorff, D. O. Effects of noncnzymatic glycosylation of mesangial matrix on proliferation ol mesangial cells. Diabetes 40:540-547; 1991.
8. Eyer, D. R. Collagen: Molecular diversity in the body's protein scaffold. Science 207:1315-1322; 1980.
9. Ikeda, K., Michelangeli, V. P., Martin, T. J., and Findlay, D. M. Type I collagen substrate increases calcitonin and parathyroid hormone receptor-mediated signal transduction in UMR 106-06 osteoblast-like cells. J Cell Physiol 156:130-137; 1993.
10. Katayama, Y., Akatsu, T., Yamamoto, M., Kugai, N., and Nagata, N. Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia. J Bone Miner Res 1996; 11:931-937; 1996.
11. Khoury, J., Thomas, C., Loike, J., Hickman, S., Cao, L., and Silverstein, S. Macrophages adhere to glucose-modified basement membrane via their scavenger receptors. J Biol Chem 269:10197-10200; 1994.
12. Kiledjian, M. and Kadesch, T. Post-transcriptional regulation of the human liver/bone/kidney alkaline phosphatase gene. J Biol Chem 266:4207-4213; 1991.
13. Lowry, O. Micromethods for the assay of enzyme. II. Specific procedures. Alkaline phosphatase. Meth Enzymol 4:371-372; 1955.
14. Noda, M. Transcriptional regulation of osteocalcin production by transforming growth factor-β in rat osteoblast-like cells. Endocrinology 124:612-617; 1989.
15. Rico, H., Hernandez, E. R., Cabranes, J. A., and Comez-Castresana, F. Suggestion of a deficient osteoblastic function in diabetes mellitus. Calcif Tissue Int 45:71-73; 1989.
16. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1989.
17. 1 (VLA-s) mediates reorganization and contraction of collagen matrices by human cells. Cell 67:403-410; 1991.
18. Schmidt, A. M., Hori, O., Brett, J., Yan, S. D., Wautier, J. L., and Stern, D. Cellular receptor for AGEs. Arterioscler Thromb 14:1521-1528; 1994.
19. Schnider, S. L. and Kohn, R. R. Effect of age and diabetes mellitus on the solubility and nonenzymatic glycosylation of human skin collagen. J Clin Invest 67:1630-1635; 1981.
20. Takeuchi, Y., Nakayama, K., and Matsumoto, T. Differentiation and cell surface expression of transforming growth factor-β receptors are regulated by interaction with matrix collagen in murine osteoblastic cells. J Biol Chem 271:3938-3944; 1996.
21. Takeuchi, Y., Fukumoto, S., and Matsumoto, T. Relationship between actions of transforming growth factor-β and cell surface expression of its receptors in clonal osteoblastic cells. J Cell Physiol 162:315-321; 1995.
22. Traianedes, K., Ng, K. W., Martin, T. J., and Findlay, D. M. Cell substratum modulates responses of preosteoblasts to retinoic acid. J Cell Physiol 157:243-252; 1993.
23. Traianedes, K., Martin, T. J., and Findlay, D. M. Regulation of osteopontin expression by type 1 collagen in preosteoblastic UMR 201 cells. Connect Tissue Res 34:63-74; 1996.
24. Wautier, J. L., Soukourian, C., Chappey, O., Wautier, M. P., Guillausseau, P. J., Cao, R., Hori, O., Stern, D., and Schmidt, A. M. Receptor mediated endothelial cell dysfunction in diabetic vasculopathy. J Clin Invest 97:238-243; 1996.
25. Wrana, J. L., Maeno, M., Hawrylyshyn, B., Yao, K. L., Domenicucci, C., and Sodek, J. Differential effects of transforming growth factor-beta on the synthesis of extracellular matrix proteins by normal fetal rat calvarial bone cell populations. J Cell Biol 106:915-924; 1988.
26. Yamada, K. M. and Miyamoto, S. Integrin transmembrane signaling and cytoskeletal control. Current Opinion Cell Biol 7:681-689; 1995.
27. Zhou, H., Hammonds, R. G., Findlay, D. M., Fuller, P. J., Martin, T. J., and Ng, K. W. Retinoic acid modulation of mRNA levels in malignant, nontransformed, and immortalized osteoblasts. J Bone Miner Res 6:767-777; 1991.